Distress and inflammation are independently associated with cancer-related symptom severity
Objective: To evaluate longitudinal associations of distress and inflammation with somatic and depressive symptom severity in breast cancer patients, from before to six months after neoadjuvant chemotherapy. We also explored feasibility and effects of an early mindfulness-based intervention for prev...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-11-01
|
| Series: | Comprehensive Psychoneuroendocrinology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666497624000456 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850053577987325952 |
|---|---|
| author | Tamara E. Lacourt D. Tripathy Maria C. Swartz Emily C. LaVoy Cobi J. Heijnen |
| author_facet | Tamara E. Lacourt D. Tripathy Maria C. Swartz Emily C. LaVoy Cobi J. Heijnen |
| author_sort | Tamara E. Lacourt |
| collection | DOAJ |
| description | Objective: To evaluate longitudinal associations of distress and inflammation with somatic and depressive symptom severity in breast cancer patients, from before to six months after neoadjuvant chemotherapy. We also explored feasibility and effects of an early mindfulness-based intervention for preventing or reducing somatic and depressive symptoms. Methods: Longitudinal pilot study with a randomized waitlist-controlled intervention design. Women with breast cancer were randomized to receive access to a smartphone application offering meditation exercises, either immediately after baseline testing (intervention group) or after study completion (control group) in a 1:1 ratio. Assessments (self-report questionnaires and a blood draw when feasible) were completed before, halfway through, immediately after, and 6 months after completing neoadjuvant chemotherapy. Results: Fifty evaluable women were enrolled. Somatic symptom severity increased during chemotherapy, whereas depressive symptom severity was at its peak before treatment and declined gradually thereafter. Distress was positively associated with depressive symptom severity. Only Distress Thermometer-results were positively associated with somatic symptom severity. Inflammation was positively associated with both types of symptoms, and distress did not moderate the associations between inflammation and symptom severity. Intervention adherence was low and no intervention effect on symptom experience was observed. Conclusion: Inflammation and distress are independently associated with somatic and depressive symptoms experienced during breast cancer treatment. |
| format | Article |
| id | doaj-art-00e5c5eafb8a4705bfbe021b9dc80d4c |
| institution | DOAJ |
| issn | 2666-4976 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Comprehensive Psychoneuroendocrinology |
| spelling | doaj-art-00e5c5eafb8a4705bfbe021b9dc80d4c2025-08-20T02:52:30ZengElsevierComprehensive Psychoneuroendocrinology2666-49762024-11-012010026910.1016/j.cpnec.2024.100269Distress and inflammation are independently associated with cancer-related symptom severityTamara E. Lacourt0D. Tripathy1Maria C. Swartz2Emily C. LaVoy3Cobi J. Heijnen4Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1055, Houston, TX, 77030-4009, USA; Corresponding author.Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1354, Houston, TX, 77030-4409, USADepartment of Pediatrics – Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1487, Houston, TX, 77030-4009, USADepartment of Health and Human Performance, University of Houston, Garrison Hall Rm 104, 3875 Holman Street, Houston, TX, 77204, USANeuroimmunology Laboratories, Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Unit 1055, 1515 Holcombe Blvd, Houston, TX, 77030-4009, USAObjective: To evaluate longitudinal associations of distress and inflammation with somatic and depressive symptom severity in breast cancer patients, from before to six months after neoadjuvant chemotherapy. We also explored feasibility and effects of an early mindfulness-based intervention for preventing or reducing somatic and depressive symptoms. Methods: Longitudinal pilot study with a randomized waitlist-controlled intervention design. Women with breast cancer were randomized to receive access to a smartphone application offering meditation exercises, either immediately after baseline testing (intervention group) or after study completion (control group) in a 1:1 ratio. Assessments (self-report questionnaires and a blood draw when feasible) were completed before, halfway through, immediately after, and 6 months after completing neoadjuvant chemotherapy. Results: Fifty evaluable women were enrolled. Somatic symptom severity increased during chemotherapy, whereas depressive symptom severity was at its peak before treatment and declined gradually thereafter. Distress was positively associated with depressive symptom severity. Only Distress Thermometer-results were positively associated with somatic symptom severity. Inflammation was positively associated with both types of symptoms, and distress did not moderate the associations between inflammation and symptom severity. Intervention adherence was low and no intervention effect on symptom experience was observed. Conclusion: Inflammation and distress are independently associated with somatic and depressive symptoms experienced during breast cancer treatment.http://www.sciencedirect.com/science/article/pii/S2666497624000456LongitudinalClinicalTranslationalOncologyPsychosocial stressBiological markers |
| spellingShingle | Tamara E. Lacourt D. Tripathy Maria C. Swartz Emily C. LaVoy Cobi J. Heijnen Distress and inflammation are independently associated with cancer-related symptom severity Comprehensive Psychoneuroendocrinology Longitudinal Clinical Translational Oncology Psychosocial stress Biological markers |
| title | Distress and inflammation are independently associated with cancer-related symptom severity |
| title_full | Distress and inflammation are independently associated with cancer-related symptom severity |
| title_fullStr | Distress and inflammation are independently associated with cancer-related symptom severity |
| title_full_unstemmed | Distress and inflammation are independently associated with cancer-related symptom severity |
| title_short | Distress and inflammation are independently associated with cancer-related symptom severity |
| title_sort | distress and inflammation are independently associated with cancer related symptom severity |
| topic | Longitudinal Clinical Translational Oncology Psychosocial stress Biological markers |
| url | http://www.sciencedirect.com/science/article/pii/S2666497624000456 |
| work_keys_str_mv | AT tamaraelacourt distressandinflammationareindependentlyassociatedwithcancerrelatedsymptomseverity AT dtripathy distressandinflammationareindependentlyassociatedwithcancerrelatedsymptomseverity AT mariacswartz distressandinflammationareindependentlyassociatedwithcancerrelatedsymptomseverity AT emilyclavoy distressandinflammationareindependentlyassociatedwithcancerrelatedsymptomseverity AT cobijheijnen distressandinflammationareindependentlyassociatedwithcancerrelatedsymptomseverity |